Home National Covaxin vs. Covishield: India’s Vaccine Battle Rages Amidst Global Scrutiny!

Covaxin vs. Covishield: India’s Vaccine Battle Rages Amidst Global Scrutiny!

Covaxin vs. Covishield India’s Vaccine Showdown Amidst Global Concerns!

In the midst of a global health crisis, India’s own Bharat Biotech steps forward with a bold claim: Covaxin, their homegrown COVID-19 vaccine, is safe and free from serious side effects. This announcement comes at a time when the world is grappling with concerns over AstraZeneca’s Covishield, which has been linked to rare but serious side effects like blood clots.

Covaxin: A Beacon of Hope? 

Bharat Biotech has confidently stated that Covaxin, developed with a focus on safety and efficacy, stands as a reliable shield against the pandemic. The company reassures that its vaccine has no known serious side effects, presenting it as a secure option for the masses.

Covishield Controversy: A Cloud of Uncertainty 

Contrastingly, AstraZeneca has faced a storm of scrutiny. Reports have emerged of legal documents submitted to a London court acknowledging that Covishield could, in very rare cases, cause blood clots and reduce platelet counts. This has raised alarms worldwide, putting the spotlight on vaccine safety.

The Legal Battle: Seeking Answers 

A group of 51 individuals has taken legal action, claiming they or their loved ones have experienced these rare symptoms after receiving the AstraZeneca vaccine. They seek answers and accountability, as the potential consequences of these side effects can be life-threatening.

#CovaxinSafety #CovishieldSideEffects #VaccineDebate #IndiaBiotech #GlobalHealthCrisis #VaccineSafety #LegalBattle #HealthNews



Please enter your comment!
Please enter your name here

Exit mobile version